Svf Pauling (Cayman) Ltd
SVF Pauling (Cayman) Ltd, 10%, reported an open-market or private sale at Relay Therapeutics, Inc. involving 6000000.000000 shares for an estimated $116400000.00. Reported holdings after the transaction were 21904963.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Aug 25, 2026
- Filing date
- Aug 28, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 27,904,963 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
RLAY price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001493152-26-040513 Common Stock
- Transaction date
- Aug 25, 2026 Filed Aug 28, 2026, 01:01 PM · 3d delay
- Shares
- 6,000,000 sh $19.40 per share
- Estimated value
- -$116M Computed from shares × price
- Holdings after
- 21,904,963 sh Indirect · See footnote
Filing signal explanations
Badges describe filing facts only — not predictions.
0 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
How this score is calculated
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
Securities held of record by SVF Pauling (Cayman) Limited, a wholly owned subsidiary of SoftBank Vision Fund (AIV M2) L.P. ("AIV M2"). SB Investment Advisers (UK) Limited ("SBIA UK") has been appointe…
0 other transactions
0 recent txs